WallStSmart

Colgate-Palmolive Company (CL)vsThe Clorox Company (CLX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 208% more annual revenue ($20.80B vs $6.76B). CLX leads profitability with a 11.2% profit margin vs 10.0%. CL appears more attractively valued with a PEG of 1.58. CL earns a higher WallStSmart Score of 58/100 (C).

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21

CLX

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.07
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+10.1%)

Margin of Safety

+10.1%

Fair Value

$98.54

Current Price

$88.58

$9.96 discount

UndervaluedFair: $98.54Overvalued
CLXSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$102.51

Current Price

$94.14

$8.37 premium

UndervaluedFair: $102.51Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$70.63B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

CLX3 strengths · Avg: 9.3/10
Return on EquityProfitability
54.6%10/10

Every $100 of equity generates 55 in profit

Debt/EquityHealth
-66.9610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.7x8/10

Attractively priced relative to earnings

Areas to Watch

CL4 concerns · Avg: 3.0/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

P/E RatioValuation
34.2x4/10

Premium valuation, high expectations priced in

Price/BookValuation
492.1x2/10

Trading at 492.1x book value

EPS GrowthGrowth
-5.9%2/10

Earnings declined 5.9%

CLX4 concerns · Avg: 3.5/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Free Cash FlowQuality
$-165.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, Debt/Equity, P/E Ratio.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 54.99 is elevated, increasing financial risk.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.55 — expect wider price swings.

CL is growing revenue faster at 8.4% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CL scores higher overall (58/100 vs 57/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Want to dig deeper into these stocks?